Effects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patients

References

• TuranVOktayKSexual and fertility adverse effects associated with chemotherapy treatment in womenExpert Opin Drug Saf201413677578324784147
   PubMed Web of Science ®Google Scholar
• PartridgeAHWinerEPLong-term complications of adjuvant chemotherapy for early stage breast cancerBreast Dis200421556415687723
   PubMedGoogle Scholar
• GadducciACosioSGenazzaniAROvarian function and childbearing issues in breast cancer survivorsGynecol Endocrinol2007231162563117926162
   PubMed Web of Science ®Google Scholar
• GarvelinkMMTer KuileMMLouweLAHildersCGStiggelboutAMA Delphi consensus study among patients and clinicians in the Netherlands on the procedure of informing young breast cancer patients about fertility preservationActa Oncol20125181062106923050612
   PubMed Web of Science ®Google Scholar
• GarvelinkMMter KuileMMFischerMJDevelopment of a decision aid about fertility preservation for women with breast cancer in the NetherlandsJ Psychosom Obstet Gynaecol201334417017824188788
   PubMed Web of Science ®Google Scholar
• CanadaALSchoverLRThe psychosocial impact of interrupted childbearing in long-term female cancer survivorsPsychooncology201221213414322271533
   PubMed Web of Science ®Google Scholar
• LorenAWManguPBBeckLNFertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline updateJ Clin Oncol201331192500251023715580
   PubMed Web of Science ®Google Scholar
• CossettiRJTyldesleySKSpeersCHZhengYGelmonKAComparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008J Clin Oncol2015331657325422485
   PubMed Web of Science ®Google Scholar
• LoboRAPotential options for preservation of fertility in womenN Engl J Med20053531647316000356
   PubMed Web of Science ®Google Scholar
• OktayKHourvitzASahinGLetrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapyJ Clin Endocrinol Metab200691103885389016882752
   PubMed Web of Science ®Google Scholar
• CasperRFMitwallyMFUse of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndromeClin Obstet Gynecol201154468569522031258
   PubMed Web of Science ®Google Scholar
• JenningaEKroepJRHildersCGLouweLAVerburgHJNortierJWFertility preservation in female oncology patientsNed Tijdschr Geneeskd20081524524372441 Dutch19051792
   PubMedGoogle Scholar
• KimJTuranVOktayKLong-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancerJ Clin Endocrinol Metab201610141364137126751194
   PubMed Web of Science ®Google Scholar
• OktayKBuyukELibertellaNAkarMRosenwaksZFertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservationJ Clin Oncol200523194347435315824416
   PubMed Web of Science ®Google Scholar
• AzimAACostantini-FerrandoMOktayKSafety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled studyJ Clin Oncol200826162630263518509175
   PubMed Web of Science ®Google Scholar
• TuranVBedoschiGMoyFOktayKSafety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patientsFertil Steril2013100616811685.e124055050
   PubMed Web of Science ®Google Scholar
• AltieriPBarisioneCLazzariniETestosterone antagonizes doxorubicin-induced senescence of cardiomyocytesJ Am Heart Assoc201651 pii: 0022383
   PubMed Web of Science ®Google Scholar
• ImaiASugiyamaMFuruiTTamayaTOhnoTDirect protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damageGynecol Obstet Invest200763210210617028438
   PubMed Web of Science ®Google Scholar
• BishopPMHarrisPWTraffordJAOestrogen treatment of recurrent aphthous mouth ulcersLancet196717504134513474165173
   PubMed Web of Science ®Google Scholar
• GiucaMRCarliEPasiniMBonfigliDCappeMREvaluation of efficacy of estrogen and phytotherapy in oral cavity alterations of women in menopauseMinerva Ginecol2009611132219204657
   PubMedGoogle Scholar
• ValimaaHSavolainenSSoukkaTEstrogen receptor-β is the predominant estrogen receptor subtype in human oral epithelium and salivary glandsJ Endocrinol20041801556214709144
   PubMed Web of Science ®Google Scholar
• Leimola-VirtanenRSaloTToikkanenSPulkkinenJSyrjanenSExpression of estrogen receptor (ER) in oral mucosa and salivary glandsMaturitas200036213113711006500
   PubMed Web of Science ®Google Scholar
• GonenneJEsfandyariTCamilleriMEffect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal womenNeurogastroenterol Motil2006181091191816961694
   PubMed Web of Science ®Google Scholar
• Oncoline. [homepage on the Internet]Cancer clinical practice guidelines “Nausea and vomiting” [updated June 16, 2014] Available from: http://www.oncoline.nl/nausea-and-vomitingAccessed July 1, 2017
   Google Scholar
• ImbertRMoffaFTsepelidisSSafety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysisHum Reprod20142991931194024958067
   PubMed Web of Science ®Google Scholar
• DonnezJDolmansMMPellicerARestoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantationFertil Steril20139961503151323635349
   PubMed Web of Science ®Google Scholar
• AndersenCYSuccess and challenges in fertility preservation after ovarian tissue graftingLancet2015385998119471948
   PubMedGoogle Scholar
• QuinnGPVadaparampilSTJacobsenPBFrozen hope: fertility preservation for women with cancerJ Midwifery Womens Health201055217518020189137
   PubMed Web of Science ®Google Scholar